Home
Portfolio
Strategy
Team
News
Contact
Investor Login
Home
Portfolio
Strategy
Team
News
Contact
Rallybio Reveals Details of Two Pipeline Programs with the Potential to Transform the Lives of Patients with Rare Diseases
Read Article
News
2021
2020
Archive
February 17, 2021
IDEAYA Biosciences Appoints Susan L. Kelley, M.D., an Industry Veteran in Medical Oncology and Clinical Development, to its Board of Directors
February 17, 2021
Cidara Therapeutics Announces New Data for Rezafungin at the 21st ICHS Symposium
February 11, 2021
Cidara Therapeutics to Present New Data for Rezafungin and Influenza AVCs at the 21st ICHS Symposium
February 11, 2021
Ensoma Announces Strategic Collaboration with Takeda to Accelerate Next-Generation In Vivo Gene Therapies
February 11, 2021
Ensoma Launches to Pioneer Next-Generation In Vivo Approach to Deliver First “Off-the-shelf” Genomic Medicines
February 10, 2021
Impel NeuroPharma Partners With Veeva Systems to Build Integrated, Digital-First Commercial Foundation
February 10, 2021
Vor Biopharma Closes Over $200M Initial Public Offering, Including Full Exercise of Option to Purchase Additional Shares
February 8, 2021
IDEAYA Announces IDE397 IND Clearance by U.S. FDA to Initiate Phase 1 and Appointment of Matthew Maurer, M.D., as Vice President, Head of Clinical Oncology and Medical Affairs
February 8, 2021
Homology Medicines Announces First Presentation of Data with HMI-203 In Vivo Gene Therapy Development Candidate for Hunter Syndrome
February 5, 2021
Vor Biopharma Announces Pricing of Initial Public Offering
« Previous Page
1
2
3
4
…
76
Next Page »
